Cite

HARVARD Citation

    Heine, A. et al. (2017). Targeting myeloid derived suppressor cells with all-trans retinoic acid is highly time-dependent in therapeutic tumor vaccination. Oncoimmunology. p. . [Online]. 
  
Back to record